Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60,026,563
-
Total 13F shares
-
19,865,806
-
Share change
-
-1,383,255
-
Total reported value
-
$136,271,026
-
Put/Call ratio
-
328%
-
Price per share
-
$6.86
-
Number of holders
-
90
-
Value change
-
-$9,942,547
-
Number of buys
-
47
-
Number of sells
-
32
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q4 2020
As of 31 Dec 2020,
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,865,806 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Avidity Partners Management LP, CITADEL ADVISORS LLC, Prosight Management, LP, Point72 Asset Management, L.P., BlackRock Inc., TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, Ghost Tree Capital, LLC, and Knoll Capital Management, LP.
This page lists
91
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.